Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry

ISSN: 1990-7508 (Print) 1990-7516 (Online)

Description

Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry   covers all major aspects of biomedical chemistry and related areas, including proteomics and molecular biology of (patho)physiological processes, biochemistry, neurochemistry, immunochemistry and clinical chemistry, bioinformatics, gene therapy, drug design and delivery, biochemical pharmacology, introduction and advertisement of new (biochemical) methods into experimental and clinical medicine. The journal also publishes review articles. All issues of the journal usually contain solicited reviews.

PEER REVIEW

Biochemistry (Moscow) Series B is a peer reviewed journal. We use a double blind peer review format. Our team of reviewers includes 84 reviewers, both internal and external (45%). The average period from submission to first decision in 2017 was 60 days, and that from first decision to acceptance was 90 days. The rejection rate for submitted manuscripts in 2017 was 60%. The final decision on the acceptance of an article for publication is made by the Editor-in-Chief and the Editorial Board.

Any invited reviewer who feels unqualified or unable to review the manuscript due to the conflict of interests should promptly notify the editors and decline the invitation. Reviewers should formulate their statements clearly in a sound and reasoned way so that authors can use reviewer’s arguments to improve the manuscript. Personal criticism of the authors must be avoided. Reviewers should indicate in a review (i) any relevant published work that has not been cited by the authors, (ii) anything that has been reported in previous publications and not given appropriate reference or citation, (ii) any substantial similarity or overlap with any other manuscript (published or unpublished) of which they have personal knowledge.

 

Browse Volumes & Issues